Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | DPP4 | P27487 | 2/20 | 0.36 |
| ▸ | PREP | P48147 | 1/20 | 0.36 |
| ▸ | FAP | Q12884 | 1/20 | 0.36 |
| ▸ | MLYCD | O95822 | 1/20 | 0.32 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.31 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.31 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.31 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12448140 | 0.92 | MLYCD (0.39) | KDM4EATMDPP4PREPFAP | |
| SCHEMBL20763391 | 0.90 | HPGD (0.39) | KDM4EATMDPP4PREPFAP | |
| SCHEMBL18718047 | 0.90 | CHRM1 (0.37) | KDM4EATMDPP4PREPFAP | |
| SCHEMBL24654814 | 0.88 | DPP4 (0.32) | KDM4EATMDPP4PREPFAP | |
| SCHEMBL22853970 | 0.88 | DPP4 (0.32) | KDM4EATMDPP4PREPFAP | |
| SCHEMBL125444 | 0.88 | DPP4 (0.32) | KDM4EATMDPP4PREPFAP | |
| SCHEMBL4546666 | 0.87 | CHRNB2 (0.44) | KDM4EATMDPP4PREPFAP | |
| SCHEMBL2293885 | 0.87 | MLYCD (0.37) | KDM4EATMDPP4PREPFAP | |
| SCHEMBL21152909 | 0.86 | DPP4 (0.31) | KDM4EATMDPP4PREPFAP | |
| SCHEMBL24591881 | 0.86 | HPGD (0.33) | KDM4EATMDPP4PREPFAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11092565-B2 | Electrochemical methods and compounds for the detection of enzymes | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2021-08-17 | — | — | US | disclosed |
| US-10408783-B2 | Electrochemical methods and compounds for the detection of enzymes | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2019-09-10 | — | — | US | disclosed |
| EP-0693466-B1 | Process for the preparation of aromatic fluorinated compounds and diamides | BAYER AG (DE) | 2001-10-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11092565-B2 | Electrochemical methods and compounds for the detection of enzymes | EPX, DNASE1, DERA | KDM4E 3018/4885ATM 3798/4885DPP4 159/4885 |
| US-10408783-B2 | Electrochemical methods and compounds for the detection of enzymes | EPX, DNASE1, DERA | KDM4E 3018/4885ATM 3798/4885DPP4 159/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.